Canopy Growth Corp vs Hershey Co — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Hershey Co trades at $171.08 (market cap $34.78B). The key difference: Hershey Co is far larger — about 87.3× Canopy Growth Corp's market cap, and Hershey Co pays a 3.39% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | HSY | |
|---|---|---|
Market Cap | $398.46M | $34.78B |
Sector | Health | Consumer Staples |
52-Week High | $1.92 | $236.28 |
52-Week Low | $0.86 | $162.31 |
Enterprise Value | $337.90M | $39.58B |
Dividend Yield | — | 3.39% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Hershey (HSY) trades at $175.24, up 0.91% on the day, with a bearish technical signal but strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, including Q1 2026 EPS of $2.35 versus $2.04 expected. Revenue growth is steady, with 2025 revenue at $11.69 billion, though net income margin compressed to 9.12% from prior years. Analyst consensus price target is $209.25, implying significant upside, supported by a 3.3% dividend yield and recent margin recovery trends.
The outlook for HSY is cautiously optimistic, with earnings momentum and valuation support offset by near-term technical weakness. Investment opportunity lies in continued execution on margin improvement and innovation, such as new REESE'S PIECES products. Key risks include persistent input cost pressures, competitive threats, and macroeconomic sensitivity. Wall Street sentiment is mixed, with 65.7% hold ratings reflecting balanced risk-reward amid recovery phase.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Hershey is a leading confectionery manufacturer in the U.S. (around a $25 billion market), controlling around 46% of the domestic chocolate space (per IRI). Beyond its namesake label, the firm's mix has expanded over the last 85 years and now consists of 100 brands, including Reese's, Kit Kat, Kisses, and Ice Breakers. Hershey's products are sold in about 80 countries, albeit with just a high-single-digit percentage of sales coming from markets outside the U.S., including Brazil, India, and Mexico. The firm has sought inorganic opportunities to extend its reach beyond its core confection business, adding Amplify Snack Brands and its Skinny Pop ready-to-eat popcorn to its mix and Pirate Brands (including the Pirate's Booty, Smart Puffs, and Original Tings brands) over the past few years.
Read more on HSY →